Cardiology – Page 43

Recent Advances in High-Intensity Interval Training: Cardiovascular, Metabolic, Diabetes, and Neuroprotective Effects

By MedXY 08/18/2025

This review synthesizes recent evidence on the benefits of high-intensity interval training (HIIT) on cardiovascular health, diabetes management, metabolic function, and neuroprotection, highlighting mechanistic insights and clinical implications.

Cardiology Clinical Updates news Specialties

Valve Underexpansion in ACURATE neo2 TAVR: Implications for Clinical Outcomes and Future Directions

By MedXY 08/17/2025

Underexpansion of the ACURATE neo2 valve during TAVR is linked to increased risk of death, stroke, and rehospitalization at one year, suggesting that achieving optimal valve expansion may improve patient outcomes.

Cardiology Diabetes & Endocrinology news Specialties

Tirzepatide’s Role in Obesity-Related HFpEF: Influence of BMI, Central Adiposity, and Weight Loss from the SUMMIT Trial

By MedXY 08/17/2025

Tirzepatide reduces heart failure risk in obese HFpEF patients regardless of BMI or central adiposity, with greater benefits on exercise capacity and symptom scores associated with higher BMI and weight loss.

Cardiology news Specialties

Thoracentesis in Acute Heart Failure: Insights from the TAP-IT Randomized Controlled Trial

By MedXY 08/17/2025

The TAP-IT trial found that additional thoracentesis in acute heart failure patients with pleural effusion did not improve days alive out of hospital, mortality, or length of stay compared to standard therapy alone.

Cardiology Clinical Updates news Specialties

Aficamten: A Breakthrough Oral Therapy for Obstructive Hypertrophic Cardiomyopathy Across Symptom Severity

By MedXY 08/17/2025

Aficamten significantly improves exercise capacity and symptoms in obstructive hypertrophic cardiomyopathy (HCM), demonstrating robust efficacy and safety in both mildly and severely symptomatic patients.

Cardiology news Specialties

Aficamten in Obstructive Hypertrophic Cardiomyopathy: Durable 48-Week Benefits and Insights on Combination Therapy

By MedXY 08/17/2025

Aficamten shows sustained obstruction relief, symptom improvement, and favorable cardiac remodeling over 48 weeks in obstructive hypertrophic cardiomyopathy, with safe discontinuation of disopyramide possible.

Cardiology Clinical Updates Nephrology news Specialties

Unraveling Molecular Links Between Chronic Kidney Disease and Heart Failure via the Plasma Proteome

By MedXY 08/17/2025

A comprehensive proteomic analysis from the ARIC study identifies plasma proteins linking kidney dysfunction to incident heart failure, highlighting potential biomarkers and therapeutic targets for HF prevention in CKD patients.

Cardiology Clinical Updates news Specialties

Left Atrial Volumetric/Mechanical Coupling Index in Heart Failure With Preserved Ejection Fraction

By MedXY 08/17/2025

This study explores the Left Atrial Coupling Index as a key predictor in heart failure patients with preserved ejection fraction.

Cardiology Clinical Updates Neurology news Specialties

Evaluating Thigh-High Compression Stockings in Preventing Vasovagal Syncope Recurrence: Insights from a Randomized Sham-Controlled Trial

By MedXY 08/17/2025

A randomized sham-controlled trial found that thigh-high elastic compression stockings did not significantly reduce vasovagal syncope recurrence or improve syncope-free survival, though fewer episodes occurred during active stocking use.

Cardiology Specialties

Optimizing Anticoagulant Therapy in Frail Elderly AF Patients: Insights from the COMBINE-AF Substudy

By MedXY 08/17/2025

Switching frail, elderly atrial fibrillation patients from warfarin to standard-dose DOAC reduced stroke, fatal and intracranial bleeding, and death, though gastrointestinal bleeding increased. Major bleeding and net clinical outcome remained similar.

Cardiology news Specialties

Vutrisiran’s Impact on Cardiac Function and Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights from HELIOS-B

By MedXY 08/17/2025

Vutrisiran improves cardiac structure, function, and biomarkers, reducing mortality and cardiovascular events in transthyretin amyloid cardiomyopathy over 30 months.

Cardiology Specialties

Evaluating Aspirin Plus Rivaroxaban versus Rivaroxaban Alone to Prevent Venous Stent Thrombosis in Post-Thrombotic Syndrome: Insights from the ARIVA Trial

By MedXY 08/17/2025

The ARIVA trial found no superior benefit of adding aspirin to rivaroxaban over rivaroxaban alone in preventing venous stent thrombosis within 6 months post-intervention in post-thrombotic syndrome patients, with both regimens showing high patency and safety.

Cardiology news Specialties

Risks and Realities of Withdrawing Heart Failure Medications After Ejection Fraction Improvement

By MedXY 08/17/2025

Withdrawal of renin-angiotensin inhibitors and mineralocorticoid receptor antagonists in patients with heart failure and improved ejection fraction significantly increases 1-year cardiovascular mortality and hospitalization risks; beta-blocker withdrawal shows varied effects based on EF.

Cardiology news Specialties

Reducing Operator Radiation Exposure in Cardiac Catheterization: Insights from the HARRA Study Comparing Left Versus Hyper-Adducted Right Radial Artery Approaches

By MedXY 08/17/2025

The HARRA study demonstrates that the left radial artery (LRA) approach significantly reduces operator radiation exposure compared to a uniform hyper-adducted right radial artery (HARRA) approach during diagnostic cardiac catheterization.

Cardiology Specialties

Comparative Effects of Nicorandil, Isosorbide Mononitrate, and Diltiazem on Radial Artery Graft Patency After CABG: Insights from the ASRAB-Pilot Trial

By MedXY 08/17/2025

The ASRAB-Pilot trial demonstrates that nicorandil and isosorbide mononitrate reduce radial artery graft failure rates post-CABG compared to diltiazem, highlighting potential advances in antispastic therapy for graft preservation.

Anesthesiology Cardiology Specialties

Optimizing Blood Transfusion Strategies in Acute Myocardial Infarction with Anemia and Heart Failure: Insights from the MINT Trial

By MedXY 08/17/2025

The MINT trial reveals that liberal transfusion strategies in MI patients with anemia, including those with heart failure, reduce adverse outcomes compared to restrictive transfusion, supporting a tailored approach to transfusion management.

Cardiology General Surgery news Specialties

Impact of Red Blood Cell Transfusion Strategies on Outcomes in Acute Myocardial Infarction Patients Undergoing Revascularization: Insights from the MINT Trial

By MedXY 08/17/2025

This prespecified analysis of the MINT trial evaluates how liberal versus restrictive red blood cell transfusion strategies affect 30-day outcomes in acute MI patients, focusing on those undergoing revascularization, revealing nuanced risk profiles for cardiac death based on revascularization status.

Cardiology news Specialties

Periprocedural Myocardial Injury after Elective PCI: Incidence and Impact on Long-Term Mortality

By MedXY 08/17/2025

Post-PCI myocardial injury defined by elevated CKMB is common and linked to increased long-term mortality, with more complex coronary anatomy predicting the injury occurrence.

Cardiology news Specialties

Assessing the Impact of Exenatide Infusion During Cardiopulmonary Bypass in CABG and Aortic Valve Replacement Surgery

By MedXY 08/17/2025

A randomized clinical trial found that exenatide infusion during and after cardiopulmonary bypass did not reduce death or major organ failure in low-risk patients undergoing coronary artery bypass grafting or aortic valve replacement.

Cardiology Specialties

Marshall-Plan Ablation Strategy Versus Pulmonary Vein Isolation in Persistent AF

By MedXY 08/17/2025

This study compares the effectiveness of the Marshall-Plan ablation strategy against pulmonary vein isolation for treating persistent atrial fibrillation.